The acetaminophen reagents market size is projected to reach US$ 0.88 billion by 2031 from US$ 0.59 billion in 2023. The market is expected to register a CAGR of 5.9% during 2023–2031. Technological advancements in immunoassay-based acetaminophen reagents will likely remain a key trend in the market.
Key factors that are driving the growth of the market are the high incidence of drug overdose and adoption of acetaminophen testing. Furthermore, the increasing number of acetaminophen overdose cases and limited players in the market would offer significant opportunities for the acetaminophen reagents market during the forecast period.
Acetaminophen is a commonly used oral antipyretic and analgesic with an excellent safety profile when administered in appropriate therapeutic doses. It is an over-the-counter (OTC) medicine and is widely available. Acetaminophen can be found in numerous products, due to which people underestimate its toxicity. Various OTC cold and flu medicines contain acetaminophen. The generalized dosage of acetaminophen in adults is up to 3,000 mg of single-ingredient acetaminophen a day and less than 3,000 mg for patients aged 65 years and above. Patients ingest excessive amounts of medicine as they misunderstand dosing directions or cannot recognize the availability of acetaminophen in more than one medication they are using.
Acetaminophen tests measure the excess amount of drug content in blood to diagnose its overdose, assess the risk of liver damage, and help decide the need for treatment. Acetaminophen toxicity is diagnosed through various diagnostic tests, such as an acetaminophen level, electrolytes, kidney function tests, and liver function tests. Proper diagnosis of acetaminophen level and accurate treatment are essential for a positive outcome. Increasing usage of OTC acetaminophen in several symptomatic treatments increases the volume for acetaminophen testing.
In the acetaminophen reagents market, there is the presence of limited key players. Therefore, they have the vast opportunity to build a trusted image among the customers, meet the surged demand for the products in the market, and adopt various strategies to gain maximum market share. The market players are focused on providing high-quality acetaminophen reagents for immunoassay testing and enzymatic assay. In addition, the growing product adoption by pathology centers and hospitals is anticipated to propel the demand for acetaminophen reagents and offer steady revenue generation to the players in the coming years. Therefore, the increasing number of acetaminophen overdose cases and limited players in the market would offer significant opportunities for the acetaminophen reagents market during the forecast period. Therefore, the increasing number of acetaminophen overdose cases and limited players in the market would offer significant opportunities for the acetaminophen reagents market during the forecast period.
Key segments that contributed to the derivation of the acetaminophen reagents market analysis are offerings, usage, and end user.
The geographic scope of the acetaminophen reagents market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
In North America, the US acetaminophen reagents market holds the largest share in the North American region. The market's growth is attributed to the increasing adoption of acetaminophen testing and product penetration. In addition, the growing incidences of overdose of acetaminophen and various risks associated with that have led to the growth of the market indirectly as the testing calls for new and advanced regents. According to the Journal of Hepatology, in the United States alone, acetaminophen overdose results in roughly 500 deaths per year, as well as close to 10,000 hospitalizations and 50,000 emergency room visits due to the same reasons.
The regional trends and factors influencing the Acetaminophen Reagents Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Acetaminophen Reagents Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ 0.59 Billion |
| Market Size by 2031 | US$ 0.88 Billion |
| Global CAGR (2023 - 2031) | 5.9% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Product
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The Acetaminophen Reagents Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Acetaminophen Reagents Market are:
Disclaimer: The companies listed above are not ranked in any particular order.
The Acetaminophen Reagents Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the acetaminophen reagents market are listed below:
The “Acetaminophen Reagents Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:
North America dominated the acetaminophen reagents market in 2023
Key factors that are driving growth of the market are high incidence of drugs overdose and adoption of acetaminophen testing.
Developments mentioned above would result in significant trends in the acetaminophen reagents market during the forecast period will likely remain a key trend in the market.
Biorbyt Ltd., American Screening Corporation Inc., Thermo Fisher Scientific Inc., Abbott, Siemens Healthineers AG, Sekisui Diagnostics, Beckman Coulter, Inc., Randox Laboratories, Ltd., EKF Diagnostics, Bio-Rad Laboratories Inc.
The market is expected to register a CAGR of 5.9% during 2023–2031.